Urša Pečar Fonović Selected Research

Carboxypeptidases

2/2022	Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors.
9/2017	Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells.
1/2015	Cathepsin X Cleaves Profilin 1 C-Terminal Tyr139 and Influences Clathrin-Mediated Endocytosis.
1/2013	Profilin 1 as a target for cathepsin X activity in tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Urša Pečar Fonović Research Topics

Disease

10	Neoplasms (Cancer) 03/2022 - 01/2013
2	Neoplasm Metastasis (Metastasis) 03/2022 - 02/2020
2	Pathologic Processes 02/2020 - 02/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 01/2013
1	Glioma (Gliomas) 02/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2022
1	Glioblastoma (Glioblastoma Multiforme) 02/2022
1	Breast Neoplasms (Breast Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

9	CathepsinsIBA 02/2022 - 01/2013
6	Cysteine (L-Cysteine)FDA Link 02/2022 - 01/2015
4	CarboxypeptidasesIBA 02/2022 - 01/2013
2	Cathepsin BIBA 01/2022 - 09/2017
2	Profilins (Profilin)IBA 01/2015 - 01/2013
1	Hormones (Hormone)IBA 03/2022
1	Endocrine DisruptorsIBA 03/2022
1	Integrin alphaVbeta3IBA 03/2022
1	IntegrinsIBA 03/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 02/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	TriazolesIBA 01/2022
1	DioxinsIBA 01/2022
1	EnzymesIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	CLIK 148IBA 09/2020
1	PerforinIBA 02/2020
1	Peptide Hydrolases (Proteases)FDA Link 02/2020
1	Proteins (Proteins, Gene)FDA Link 02/2020
1	Granzymes (Granzyme)IBA 02/2020
1	ClathrinIBA 01/2015
1	polyprolineIBA 01/2015
1	LigandsIBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2022 - 09/2020